ARCHIVES

Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

NCI-Approved Clinical Trials

July 29, 2005

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002

Prime Contract Subcontract Opportunities

January 24, 1975

Edelson to Direct Yale Cancer Center (12-page issue).

May 30, 2003